Top compounds associated with response to CTNNBL1


Feature Type Standardized
Nominal ANOVA
mRNA dexamethasone CTRPv2 pan-cancer AAC 0.19 4e-09
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 4e-07
mRNA decitabine CTRPv2 pan-cancer AAC 0.13 1e-06
mRNA BRD-K02251932 CTRPv2 pan-cancer AAC 0.18 3e-06
mRNA Methotrexate GDSC1000 pan-cancer AAC 0.13 2e-05
mRNA FH535 GDSC1000 pan-cancer AAC -0.14 7e-05
mRNA AZD1480 CTRPv2 pan-cancer AAC 0.19 0.0002
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.0002
mRNA Cytarabine CTRPv2 pan-cancer AAC 0.1 0.0003
mRNA WZ3105 GDSC1000 pan-cancer AAC 0.11 0.0004
Download CSV